ASS1P10: A Promising Drug Target and Biomarker for Argininosuccinate Synthetase 1 Pseudogene 10

Target Name: ASS1P10

NCBI ID: G455

ASS1P10

Other Name(s): Argininosuccinate synthetase 1 pseudogene 10 | ASSP10 | argininosuccinate synthetase 1 pseudogene 10

ASS1P10: A Promising Drug Target and Biomarker for Argininosuccinate Synthetase 1 Pseudogene 10

Introduction

Argininosuccinate synthetase 1 (AS1) is a key enzyme in the urea cycle, which is involved in the production of urine, cold wind, and ammonia from amino acids. The pseudogene, AS1P10, has been identified in various organisms, including humans, and has been shown to be involved in various physiological processes. Although AS1P10 has been studied extensively, its functions and potential as a drug target or biomarker remain unexplored. In this article, we will explore the AS1P10 gene, its expression, and its potential as a drug target.

Expression and Localization

AS1P10 is a gene that encodes a protein involved in the urea cycle. The protein is composed of 254 amino acids and has a calculated molecular weight of 31 kDa. AS1P10 is expressed in various tissues and organs, including liver, muscle, heart, kidney, and pancreas. The highest levels of AS1P10 expression were found in the hearts, followed by the livers and kidneys.

Localization of AS1P10 has been studied using various techniques, including gene expression microarray analysis and biochemical assays. Results have shown that AS1P10 is expressed in the hearts and is involved in the urea cycle. Additionally, immunofluorescence studies have shown that AS1P10 is localized to the endoplasmic reticulum (ER) and the nuclear envelope (NE).

Function and Interaction

AS1P10 is a key enzyme in the urea cycle, responsible for the production of ammonia and uracil from amino acids. The urea cycle is a crucial process for maintaining cellular homeostasis and is involved in the production of various amines, including nitrogen, which are essential for life. AS1P10 is also involved in the production of carbon dioxide, which is essential for the production of energy in the form of ATP.

In addition to its role in the urea cycle, AS1P10 has been shown to be involved in various signaling pathways. For example, AS1P10 has been shown to be involved in the regulation of cell apoptosis, which is a critical mechanism that helps maintain cellular homeostasis. Additionally, AS1P10 has been shown to be involved in the regulation of cell growth and has been shown to play a role in the development of cancer.

Drug Target Potential

AS1P10 has been identified as a potential drug target due to its involvement in various physiological processes. The urea cycle is a key pathway for the production of various amines, including nitrogen, which are essential for life. AS1P10 is involved in the production of these amines , making it an attractive target for drugs that can modulate the urea cycle.

In addition, AS1P10 has been shown to be involved in various signaling pathways, including cell apoptosis and cell growth. AS1P10 has been shown to play a role in the regulation of cell apoptosis, which is a critical mechanism that helps maintain cellular homeostasis. Additionally, AS1P10 has been shown to play a role in the regulation of cell growth, which is essential for the development and maintenance of tissues and organs.

Biomarker Potential

AS1P10 has also been identified as a potential biomarker for various diseases, including cancer. The urea cycle is a critical pathway for the production of various amines, including nitrogen, which are essential for life. AS1P10 has been shown to be involved in the production of these amines, making it an attractive target for biomarkers that can

Protein Name: Argininosuccinate Synthetase 1 Pseudogene 10

The "ASS1P10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ASS1P10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets